BR112015001019A2 - uso de um agente quelante anfotérico para prevenir alergias de contato - Google Patents
uso de um agente quelante anfotérico para prevenir alergias de contatoInfo
- Publication number
- BR112015001019A2 BR112015001019A2 BR112015001019A BR112015001019A BR112015001019A2 BR 112015001019 A2 BR112015001019 A2 BR 112015001019A2 BR 112015001019 A BR112015001019 A BR 112015001019A BR 112015001019 A BR112015001019 A BR 112015001019A BR 112015001019 A2 BR112015001019 A2 BR 112015001019A2
- Authority
- BR
- Brazil
- Prior art keywords
- chelating agent
- amphoteric chelating
- contact allergies
- prevent contact
- amphoteric
- Prior art date
Links
- 239000002738 chelating agent Substances 0.000 title abstract 4
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 3
- 230000007815 allergy Effects 0.000 title abstract 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052782 aluminium Inorganic materials 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/51—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
resumo de patente de invenção para: uso de um agente quelante anfotérico para prevenir alergias de contato. a invenção se refere à utilização de pelo menos um agente quelante anfotérico que compreende um complexo baseado em alumínio e em ácido etilenodiaminotetracético ou o sal trissódico do mesmo, tendo a fórmula geral [al (y) bn]c'dc com b sendo oh-, bo2- ou h+, y sendo um tetracarboxilato que pode ser protonado quatro vezes, de modo a formar o ácido etilenodiaminotetracético, n sendo um número inteiro igual a 0, 1, 2 ou 3, d sendo um contra-íon, de preferência, na+, c sendo um inteiro igual a 0, 1, 2 ou 3 e c' sendo um número relativo tendo o mesmo valor absoluto como c para a prevenção de alergias de contato. refere-se também a um dispositivo, uma parte do qual compreende o referido agente quelante anfotérico
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1256939A FR2993466B1 (fr) | 2012-07-18 | 2012-07-18 | Utilisation d'une creme de protection contre les effets des agents chimiques agressifs en contact avec la peau |
FR1256939 | 2012-07-18 | ||
PCT/FR2013/051718 WO2014013195A1 (fr) | 2012-07-18 | 2013-07-17 | Utilisation d'un agent chelatant amphotere pour prevenir les allergies de contact |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112015001019A2 true BR112015001019A2 (pt) | 2017-06-27 |
BR112015001019B1 BR112015001019B1 (pt) | 2022-07-19 |
Family
ID=47137836
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015001019-9A BR112015001019B1 (pt) | 2012-07-18 | 2013-07-17 | Uso de um agente quelante anfotérico para prevenir alergias de contato |
BR112015001018-0A BR112015001018B1 (pt) | 2012-07-18 | 2013-07-17 | Uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015001018-0A BR112015001018B1 (pt) | 2012-07-18 | 2013-07-17 | Uso de um creme que protege contra os efeitos de agentes químicos agressivos em contato com a pele |
Country Status (18)
Country | Link |
---|---|
US (3) | US11197874B2 (pt) |
EP (2) | EP2874661B1 (pt) |
CN (4) | CN104470501A (pt) |
AU (2) | AU2013291793B2 (pt) |
BR (2) | BR112015001019B1 (pt) |
CA (2) | CA2878650C (pt) |
DK (2) | DK2874661T3 (pt) |
ES (2) | ES2690060T3 (pt) |
FR (1) | FR2993466B1 (pt) |
IN (1) | IN2014DN10924A (pt) |
MX (2) | MX356811B (pt) |
NO (1) | NO2874604T3 (pt) |
NZ (2) | NZ703409A (pt) |
PL (2) | PL2874661T3 (pt) |
PT (1) | PT2874604T (pt) |
SI (1) | SI2874661T1 (pt) |
TR (1) | TR201815143T4 (pt) |
WO (2) | WO2014013194A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3093001B1 (fr) * | 2019-02-22 | 2022-06-10 | Prevor Int | Composition pour enlever des residus chimiques et ses utilisations |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2604900B1 (fr) * | 1986-10-08 | 1989-01-13 | Blomet Marie Claude | Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
US5587400A (en) * | 1993-04-19 | 1996-12-24 | Marie-Claude Blomet epouse Meyer | Physiological composition for the treatment of thermal or chemical burns |
US5665804A (en) * | 1996-02-05 | 1997-09-09 | Dow Corning Corporation | Silicone latex solvent thickening |
SE9604610D0 (sv) * | 1996-12-16 | 1996-12-16 | Noviscens Ab | Medical composition |
US6242042B1 (en) * | 1998-09-14 | 2001-06-05 | Lrc Products Ltd. | Aqueous coating composition and method |
US6582683B2 (en) * | 2000-01-04 | 2003-06-24 | Skinvisible Pharmaceuticals, Inc. | Dermal barrier composition |
FR2809959B1 (fr) * | 2000-06-07 | 2004-10-29 | Marie Claude Meyer | Utilisation d'un complexe d'aluminium et de ligand ethylenediamine-tetraacetique pour la prevention et/ou le traitement des urticaires |
GB0403702D0 (en) * | 2004-02-19 | 2004-03-24 | Boots Co Plc | Skincare compositions |
US20070232681A1 (en) * | 2003-10-14 | 2007-10-04 | Oxagen Limited | Compounds Having Crth2 Antagonist Activity |
GB0324084D0 (en) * | 2003-10-14 | 2003-11-19 | Oxagen Ltd | Compounds |
EP1851669B1 (en) * | 2005-02-02 | 2015-07-08 | POCRASS, Alan L. | Data storage and transfer device and method |
EP2238183B1 (en) * | 2008-01-18 | 2019-02-27 | Vystar Corporation | Natural rubber latex having reduced allergenicity and method of making |
WO2011041680A2 (en) * | 2009-10-02 | 2011-04-07 | The Brigham And Women's Hospital, Inc. | Compositions and methods of prophylaxis for contact dermatitis |
-
2012
- 2012-07-18 FR FR1256939A patent/FR2993466B1/fr active Active
-
2013
- 2013-07-17 CA CA2878650A patent/CA2878650C/fr active Active
- 2013-07-17 WO PCT/FR2013/051717 patent/WO2014013194A1/fr active Application Filing
- 2013-07-17 PL PL13747451T patent/PL2874661T3/pl unknown
- 2013-07-17 NO NO13747452A patent/NO2874604T3/no unknown
- 2013-07-17 NZ NZ703409A patent/NZ703409A/en unknown
- 2013-07-17 CN CN201380037698.8A patent/CN104470501A/zh active Pending
- 2013-07-17 CN CN201380037758.6A patent/CN104507501A/zh active Pending
- 2013-07-17 BR BR112015001019-9A patent/BR112015001019B1/pt active IP Right Grant
- 2013-07-17 DK DK13747451.6T patent/DK2874661T3/en active
- 2013-07-17 AU AU2013291793A patent/AU2013291793B2/en active Active
- 2013-07-17 PL PL13747452T patent/PL2874604T3/pl unknown
- 2013-07-17 EP EP13747451.6A patent/EP2874661B1/fr active Active
- 2013-07-17 TR TR2018/15143T patent/TR201815143T4/tr unknown
- 2013-07-17 EP EP13747452.4A patent/EP2874604B1/fr active Active
- 2013-07-17 CN CN201810186400.4A patent/CN108606964A/zh active Pending
- 2013-07-17 WO PCT/FR2013/051718 patent/WO2014013195A1/fr active Application Filing
- 2013-07-17 US US14/415,146 patent/US11197874B2/en active Active
- 2013-07-17 US US14/415,428 patent/US10953024B2/en active Active
- 2013-07-17 CN CN201910485746.9A patent/CN110179686A/zh active Pending
- 2013-07-17 BR BR112015001018-0A patent/BR112015001018B1/pt active IP Right Grant
- 2013-07-17 IN IN10924DEN2014 patent/IN2014DN10924A/en unknown
- 2013-07-17 AU AU2013291792A patent/AU2013291792B2/en active Active
- 2013-07-17 MX MX2015000786A patent/MX356811B/es active IP Right Grant
- 2013-07-17 DK DK13747452.4T patent/DK2874604T3/en active
- 2013-07-17 SI SI201331206T patent/SI2874661T1/sl unknown
- 2013-07-17 ES ES13747451.6T patent/ES2690060T3/es active Active
- 2013-07-17 CA CA2878882A patent/CA2878882C/fr active Active
- 2013-07-17 NZ NZ703258A patent/NZ703258A/en unknown
- 2013-07-17 MX MX2015000785A patent/MX359747B/es active IP Right Grant
- 2013-07-17 ES ES13747452.4T patent/ES2667709T3/es active Active
- 2013-07-17 PT PT137474524T patent/PT2874604T/pt unknown
-
2021
- 2021-02-10 US US17/172,434 patent/US20210275553A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014022178A2 (pt) | reparo sem nó baseado em sutura | |
BR112015021456A2 (pt) | uso tópico de uma formulação antimicrobiana | |
BR112015014089A2 (pt) | composições pesticidas e processos relacionados às mesmas | |
BR112015001414A2 (pt) | composição antideriva | |
BR112014029762A2 (pt) | composição contendo n-metil-n-acilglucamina | |
BR102012002852A8 (pt) | composições pesticidas e processos relacionados das mesmas | |
CO7111285A2 (es) | Composiciones pesticidas y procesos relacionados con ellas | |
BR112014002189A2 (pt) | ferramenta de poço com mecanismo de indexação e método | |
BR112012019144A2 (pt) | suporte de cartucho, dispositivo de distribuição de fármaco e método para fixação de um cartucho em um suporte de cartucho | |
BR112014012524A2 (pt) | composições compreendendo um componente de estabilidade do prazo de validade | |
BR112015021352A2 (pt) | composições antimicrobianas | |
BR112017004524A2 (pt) | pirrolopirimidinas para uso na infecção pelo vírus da gripe | |
BR112014005810A2 (pt) | formas sólidas de um inibidor da dissociação de transtirretina | |
BR112015007546A2 (pt) | composições de ácido percarboxílico estáveis e usos das mesmas | |
BR112014013780A2 (pt) | transportador de seringa | |
CO6741214A2 (es) | Composiciones pesticidas y procesos relacionados | |
BR112012033077B8 (pt) | Composição farmacêutica para administração intravenosa, uso de uma composição farmacêutica, e, kit | |
BR112015017251A2 (pt) | composições farmacêuticas compreendendo doadores de nitroxil | |
CL2011000135A1 (es) | Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica. | |
CU20120171A7 (es) | Triazolopiridinas sustituidas | |
BR112013024424A2 (pt) | recipiente, dispositivo de fixação, sistema de fixação e aplicador de injeção | |
BR112015023387A2 (pt) | composições lipídicas de racecodotril | |
BR112015027734A2 (pt) | Sistema de mudança rápida para ferramentas rotatórias | |
BR112016008871A8 (pt) | sonda de imageamento tau, seu método de produção composição farmacêutica, kit, uso, métodos de separação de compostos racêmico | |
BR112015030088A2 (pt) | aprimoramentos em ou referentes a compostos orgânicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/07/2013, OBSERVADAS AS CONDICOES LEGAIS |